Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.78
-0.0100-0.04%
Pre-market: 27.940.1600+0.58%09:20 EDT
Volume:29.14M
Turnover:810.84M
Market Cap:157.95B
PE:36.56
High:27.98
Open:27.76
Low:27.57
Close:27.79
52wk High:29.21
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.89
T/O Rate:0.52%
Dividend:1.72
Dividend Rate:6.19%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.85
PE(LYR):20.36

Loading ...

Pfizer - Shipping of Xfg-Adapted Covid-19 Vaccine to Begin Immediately

THOMSON REUTERS
·
Aug 28

Pfizer - 2026-2027 Covid-19 Vaccine Formula Targets Xfg Variant Per FDA Guidance

THOMSON REUTERS
·
Aug 28

Pfizer’s Korean Vyndamax Study Update: What It Means for ATTR-CM Investors

TIPRANKS
·
Aug 28

China's Drug Regulator Accepts Novo Nordisk's Application for Oral Wegovy

Reuters
·
Aug 27

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Pfizer Stock (PFE) Is a Buy despite Declining Revenues

TIPRANKS
·
Aug 24

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 24

Pfizer Shows Signs of Stabilization as New Drug Revenue Surges 18%, Yet Patent Expirations Remain the Ultimate Hurdle

Stock News
·
Aug 24

Pfizer’s Quiet Trial Wave Hints at Big Pipeline Upside

TIPRANKS
·
Aug 22

Is The Depo-Provera Meningioma Settlement Reshaping Legal Risk In Pfizer’s Investment Case (PFE)?

Simply Wall St.
·
Aug 22

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Aug 22

Pfizer’s India Migraine Study Adds Real-World Momentum for PFE

TIPRANKS
·
Aug 22

Pfizer’s Real World Prostate Cancer Study Sets Up a New Test for Leading Therapies

TIPRANKS
·
Aug 22

Pfizer’s Atirmociclib Study Marks Quiet but Important Step in Pipeline Progress

TIPRANKS
·
Aug 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Innoviva (INVA) and Pfizer (PFE)

TIPRANKS
·
Aug 21

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

NYSE Most Active Issues

Dow Jones
·
Aug 21

Cboe data shows mixed options sentiment in Pfizer with shares down 1.5%

TIPRANKS
·
Aug 21

Pfizer’s Ibrance Real-World Breast Cancer Study Wraps Up: What Investors Should Watch Next

TIPRANKS
·
Aug 21

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20